Literature DB >> 29214908

Prospective memory in first-degree relatives of patients with schizophrenia.

Saima Saleem1, Devvarta Kumar2, Ganesan Venkatasubramanian3.   

Abstract

OBJECTIVES: Among various cognitive impairments in schizophrenia, prospective memory (ProM) deficit is unequivocally established. However, there is a paucity of research examining whether ProM impairment can be considered a cognitive endophenotypic marker in schizophrenia. An important step toward this is to assess the status of ProM in first-degree relatives (FDRs) of patients with schizophrenia. Keeping this in view, present study has been conducted to assess event- and time-based ProM in FDRs of patients with schizophrenia.
METHODS: Twenty patients with schizophrenia, 20 FDRs of these patients, and 20 nonpsychiatric (healthy) controls were administered event- and time-based ProM tasks.
RESULTS: Findings show that the FDRs had poorer performance on event-based ProM task in comparison to healthy controls. On time-based task, though the FDRs performed poorly in comparison to healthy controls the difference was statistically non-significant. The patient group performed poorer than healthy controls on both event- and time-based tasks.
CONCLUSIONS: Findings of the present study indicate that the FDRs of patients with schizophrenia exhibit ProM impairment, though to a lesser degree than the patients with schizophrenia.

Entities:  

Keywords:  Prospective memory; Schizophrenia; first-degree relatives

Mesh:

Year:  2017        PMID: 29214908     DOI: 10.1080/13854046.2017.1406145

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  1 in total

1.  Nonverbal communication remains untouched: No beneficial effect of symptomatic improvement on poor gesture performance in schizophrenia.

Authors:  Florian Wüthrich; Anastasia Pavlidou; Katharina Stegmayer; Sarah Eisenhardt; Jeanne Moor; Lea Schäppi; Tim Vanbellingen; Stephan Bohlhalter; Sebastian Walther
Journal:  Schizophr Res       Date:  2020-09-01       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.